|
(Health-NewsWire.Net, May 12, 2021 ) The report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecasts“, the cell harvesters market is expected to reach USD 324.5 Million, at a CAGR of 8.7%
The research report aims to provide insights into the global market for cell harvesting. It provides valuable information on cell harvesting type, application, and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.
What Drives the Cell Harvesting Market Growth?
Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bio processing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays.
The Factors such as rising investments in Regenerative Medicine and cell-based research, growth of the biotechnology and bio pharmaceutical industry, and increasing incidence of chronic and infectious diseases are contributing to the growth of this market.
Don’t miss out on business opportunities in “Cell Harvesters Market”.
Speak to Our Analyst and gain crucial industry insights that will help your business growth: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=209513544
Market Segmentation in Detailed:
On the basis of type, the market is segmented into manual and automated cell harvesters. In 2017, the manual cell harvesters segment accounted for the largest share of this market. The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.
In the end user, the cell harvesting market is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users. In 2017, the biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market. The high share of this segment can be attributed to the high prevalence of chronic diseases. Biotechnology & biopharmaceutical companies conduct R&D activities to develop new products for the treatment of these diseases.
Geographical View in-detailed:
the global cell harvesting market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America held the largest share of the market in 2017, Asia Pacific is expected to register the highest CAGR during the forecast period. As increasing R&D expenditure helps in the development of new treatment solutions, supportive government policies for stem cell research and increasing public-private initiatives to encourage public adoption of stem cell-based treatment in the Asia Pacific countries are driving the growth of the market in this region.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209513544
Global Key Leaders:
Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
